Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study
Sirui Fu(Jinan University), Ligong Lu(Tongji University), Xiaoqun Li(Second Military Medical University), Chongyang Duan(Southern Medical University), Dongsheng Gu(Wuhan University of Technology), Jingwei Wei(Chinese Academy of Sciences), Jiangdian Song(China Medical University), Shuaitong Zhang(Chinese PLA General Hospital), Yong Li(Jinan University), Jie Tian(Shanghai Jiao Tong University), Jie Zhang(Jinan University), Xiaofeng He(Nanfang Hospital), Di Dong(Chinese Academy of Sciences), Jianfeng Yan(Qujiang People's Hospital), Zhenyu Liu(Shanxi Agricultural University), Xudong Chen(Hangzhou First People's Hospital), Xiaohan Hao(South China University of Technology)
Cited by 18
Related Papers
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges
|Theranostics|2019|1k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
|Clinical Cancer Research|2017|562
Central focused convolutional neural networks: Developing a data-driven model for lung nodule segmentation
|Medical Image Analysis|2017|489
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
|European Respiratory Journal|2019|441